Answers are grounded in this paper and cite their sources.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common monogenic small vessel disease, is caused by cysteine-altering mutations in the neurogenic locus notch homolog protein 3 gene, which disrupt vascular smooth muscle cell function through protein misfolding and impaired vascular reactivity. Neuroimaging, particularly high-resolution magnetic resonance imaging, reveals characteristic white matter hyperintensities, and advanced imaging combined with deep learning enhances diagnostic precision. Blood neurofilament light chain is an emerging biomarker. Genetic counselling is crucial for early diagnosis and family screening. Current management involves vascular risk reduction, migraine control, and supportive care. Investigational therapies, including monoclonal antibodies, exon-skipping antisense oligonucleotides, CRISPR-based gene editing, and ongoing trials such as AMCAD and tocotrienol (NCT04658823), hold promise. Challenges remain in biomarker validation, therapeutic translation, and equitable access to diagnostics, highlighting the need for international collaboration to optimise CADASIL care.
No takes yet. Share an insight, caveat, or question.
Marni et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: